Article
Monitoring Effects of Excipients, Formulation Parameters and Mutations on the High Order Structure of Filgrastim by NMR.
Pharmaceutical research - 1 Oct 2015
Aubin Yves, Hodgson Derek J, Thach William B, Gingras Geneviève, Sauvé Simon
Abstract excerpt
PURPOSE: Filgrastim is the generic name for recombinant methionyl human granulocyte colony-stimulating factor (r-metHuG-CSF). It is marketed under the brand name Neupogen® by Amgen. Since this product has lost patent protection, many biosimilar versions have been approved or are in the process of filing for market authorization throughout the world. Here we show that NMR spectroscopy can be used to assess the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
